Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions

International Angiology

Volumn 22, Issue 3, 2003, Pages 222-228

  Elhadd, Tarik A ^a,c   Neary, R ^a   Abdu, T A M ^a   Kennedy, G ^b   Hill, A ^b   McLaren, M ^b   Akber, M ^a   Belch, J J F ^b   Clayton, R N ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Altherosclerosis; Cell adhesion molecules; Free radicals; Homocysteine; Menstrual cycle

Indexed keywords

ALPHA TOCOPHEROL; CELL ADHESION MOLECULE; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN; FREE RADICAL; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; SEX HORMONE; TRIACYLGLYCEROL;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LINEAR REGRESSION ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUATION; NORMAL HUMAN; PREMENOPAUSE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADULT; BLOOD GLUCOSE; CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; FREE RADICALS; GONADAL STEROID HORMONES; HOMOCYSTEINE; HUMANS; LIPIDS; MENSTRUAL CYCLE; PREMENOPAUSE; PROGESTERONE;

EID: 0345328649     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Barrett-Connor E, Bush TL. Oestrogen and coronary artery disease in women. JAMA 1991;265:1861-7.
2. Vita JA, Keaney JF, Loscalzo J. Endothelial dysfunction of vascular disease. In: Creager MA, Loscalzo J editors. Textbook of vascular medicine. Noston: Plenum Press; 1994.p.245-63.
3. Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998;104: 5520-8.
4. Tagawa H, Shimokawa H, Tagawa T, Kuriowa-Matsumoto M, Hiroka Y, Ytakeshita A. Short-term eostrogen augments both nitric oxide-mediated and no-nitric oxide mediated endothelium dependent forearm vasodilatation in postmenopausal women. J Cardiovasc Pharmacol 1997;30:481-8.
5. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K et al. Modulation of endothelial dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995;92:3431-5.
6. Arora S, Veves A, Caballaro AE, Smakowski P, Logergo FW. Estrogen improves endothelial function. J Vasc Surg 1998;27:1141-6.
7. Wellman GC, Brayden JE, Nelson MT. A proposed mechanism for the cardioprotective effect of oestrogen in women: enhanced endothelial nitric oxide release decreases coronary artery reactivity. Clin Exp Pharmacol Physiol 1996;23:260-6.
8. Hayashi T, Fukuto JM, Ingarro LJJ, Chauduri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Nat Acad Sci U S A 1992;89:11259-63.
9. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium- ndependent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991;104:1033-7.
10. Bush TL, Fried LP, Barrett-Conor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem 1988;34:B60-B70.
11. Lussiers-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr. Plasma total homocysteine in healthy subjects: sex specific relation with biological traits. Am J Clin Nutr 1996;64:587-93.
12. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-5.
13. Van der Mooren MJ, Wouters MG, Blom HJ, Schellekens LA, Eskes TK, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994;24:733-6.
14. Finklestein JD. Methionine metabolism in mammals. Effect of age, diet, and hormones on three enzymes of the pathway in rat tissues. Arch Biochem Biophys 1962;122:583-90.
15. Fonseca V, Guba S, Fink LM. Hypermocysteinaemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev 1999;20:738-59.
16. Keaney JF, Shwery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL et al. 17β-oestradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolaemic swine. Circulation 1994;89:2251-9.
17. Yagi K, Komura S. Inhibitory effect of female hormones on lipid peroxidation. Biochem Int 1986;13:1051-5.
18. Nathan L, Chaudhuri G. Antioxidant and pro-oxidant actions of oestrogens: potential physiological and clinical implications. Sem Reprod Endocrinol 1998;16:309-14.
19. Maple C, Kirk G, McLaren M, Belch JJF. Circadian variation exists for soluble ICAM-1 and E-selectin in healthy volunteers. Clin Sci 1998;94:537-40.
20. Tatum VL, Changechi C, Chow CK. Measurement of malondialdehyde by high performance liquid chromatography with fluorescence detection. Lipids 1990;25:226-9.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-520.
22. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996;94:727-33.
23. Williams JK, Adams MR, Klopfstein HS. Oestrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-7.
24. Mendelsohn ME, Karas RH. The protective effects of oestrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.
25. Kennedy G, McLaren M, Belch JJF, Seed M. Elevated levels of sE-selectin in postmenopausal females are decreased by hormone replacement therapy to levels observed in premenopausal females. Thromb Haemost 1999;82: 1433-6.
26. Caulin-Glaser T, Farrell WJ, Pfau SE, Zaret B, Bunger K, Setaro JF et al. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. J Am Coll Cardiol 1998;31:1555-60.
27. Cronstein BN, Weissman G. The adhesion molecules of inflammation. Arthritis Rheum 1993;36:147-57.
28. Berger PB, Herrmann RR, Dunesic DA. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clinic Proc 2000;75:18-23.
29. Anker G, Lonning PE, Ueland PM, Refsum H, Lien EA. Plasma levels of atherogenic amino acid homocysteine in postmenopausal women with breast cancer. Int J Cancer 1995;60:365-8.
30. Graham IM, Daly LE, Refsum H, Robinson J, Brattstrom LE, Ueland PM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
31. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischaemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 1998;158:862-7.
32. Nygaard O, Vollset SE, Refsum H, Stensfold I, Tverdal A, Nordrehaug JE et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526-33.
33. O K, Lynn EG, Chung YH, Siow YL, Man RY, Choy PC. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochem Biophys Acta 1998;1393:317-24.
34. Zulli A, Buxton B, Doolan L, Liu JJ. Effect of homocysteine and cholesterol in raising plasma homocysteine, cholesterol and triglyeride levels. Life Sci 1998;62: 2191-4.
35. Maziere C, Auclair M, Ronveaux MF, Salmon S, Santus R, Maziere JC. Estrogen inhibits copper and cell-mediated modification of low density lipoproteins. Atherosclerosis 1991;89:175-82.
36. Anderson WA, Kang YH, De Sombre ER. Endogenous peroxidase: specific marker enzyme for tissues displaying growth dependency on estrogen. J Cell Biol 1975;64: 668-81.
37. Arnal JF, Clamens S, Peschet C, Negre-Salvayre A, Allera C, Girolami JP et al. Ethylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Nat Acad Sci U S A 1996;93:4108-13.
38. Massafra C, De Felice C, Gioia D, Buonocore G. Variations in erythrocyte anti-oxidant glutathione peroxidase activity during the menstrual cycle. Clin Endocrinol 1998;49:63-8.